CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Net Cash Flow Growth by Quarter and Year

Atara Biotherapeutics Inc 's Net Cash Flow results by quarter and year




ATRA Net Cash Flow (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December 0.00 - 18.73 21.61
III Quarter September - - -3.74 4.30
II Quarter June -1.54 - 1.81 -1.69
I Quarter March - - 14.46 -30.72
FY   -1.54 - 31.26 -6.50



ATRA Net Cash Flow forth quarter 2018 Y/Y Growth Comment
Atara Biotherapeutics Inc in the forth quarter recorded net cash outflow of $ 0.00 millions.

According to the results reported in the forth quarter, Atara Biotherapeutics Inc achieved the best Net Cash Flow growth in Biotechnology & Drugs industry. While Atara Biotherapeutics Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the forth quarter.




ATRA Net Cash Flow ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - -13.33 % -23.59 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics Inc 's forth quarter 2018 Net Cash Flow $ 0.00 millions ATRA's Income Statement
Atara Biotherapeutics Inc 's forth quarter 2017 Net Cash Flow $ 0.00 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Net Cash Flow Growth >>


ATRA Net Cash Flow (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - 402.56 %
III Quarter September - - - -
II Quarter June - - -87.48 % -
I Quarter March - - -33.09 % -
FY (Year on Year)   - - - -




Net Cash Flow forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Atara Biotherapeutics Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's IV. Quarter Q/Q Net Cash Flow Comment


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's IV. Quarter Q/Q Net Cash Flow Comment


Atara Biotherapeutics Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
Cumulative Net Cash Flow 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
In the Dec 31 2019 period, Atara Biotherapeutics Inc 's cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.

Atara Biotherapeutics Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
In the Dec 31 2019 period, Atara Biotherapeutics Inc 's cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.

Atara Biotherapeutics Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Biotechnology & Drugs Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
ATRA's Net Cash Flow Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for ATRA's Competitors
Net Cash Flow Growth for Atara Biotherapeutics Inc 's Suppliers
Net Cash Flow Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2019
Xtl Biopharmaceuticals Ltd -1.03 %$ -1.034 millions
Benitec Biopharma Ltd -7.42 %$ -7.424 millions
Ovid Therapeutics Inc -9.52 %$ -9.519 millions
National Research Corporation -9.78 %$ -9.776 millions
Taiwan Liposome Company Ltd -13.17 %$ -13.171 millions
Cutera Inc -17.89 %$ -17.893 millions
Lifevantage Corp -21.22 %$ -21.222 millions
Fonar Corp -23.86 %$ -23.857 millions
Sanofi -24.81 %$ -24.809 millions
Trillium Therapeutics Inc -29.49 %$ -29.490 millions
Biolinerx Ltd -33.39 %$ -33.386 millions
Xoma Corp -37.12 %$ -37.119 millions
Morphosys Ag -40.64 %$ -40.645 millions
Biohaven Pharmaceutical Holding Company Ltd -44.33 %$ -44.331 millions
Johnson and Johnson -48.51 %$ -48.513 millions
Genetic Technologies Ltd -50.06 %$ -50.065 millions
Viveve Medical Inc -55.21 %$ -55.209 millions
Kazia Therapeutics Ltd -58.80 %$ -58.796 millions
Biotelemetry Inc -60.38 %$ -60.379 millions
Regeneron Pharmaceuticals Inc -60.49 %$ -60.489 millions
Invitae Corporation -60.87 %$ -60.868 millions
Orthopediatrics Corp -68.71 %$ -68.709 millions
Yield10 Bioscience Inc -78.56 %$ -78.560 millions
Sonoma Pharmaceuticals, Inc. -79.78 %$ -79.779 millions
Lipocine Inc -83.27 %$ -83.267 millions
Encision Inc -87.11 %$ -87.112 millions
Natus Medical Inc -87.84 %$ -87.843 millions
Harvard Bioscience Inc -89.29 %$ -89.286 millions
Molecular Templates Inc -91.87 %$ -91.868 millions
Cba Florida Inc -95.11 %$ -95.110 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMTX's Profile

Stock Price

SMTX's Financials

Business Description

Fundamentals

Charts & Quotes

SMTX's News

Suppliers

SMTX's Competitors

Customers & Markets

Economic Indicators

SMTX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071